GO:0042012 interleukin-16 receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042012 (interleukin-16 receptor activity) is a molecular function defined as combining with interleukin-16 (IL-16) and transmitting a signal across the membrane to initiate a change in cell activity.
• IL-16 is a pleiotropic cytokine that signals through the CD4 receptor and can also act via CD4-independent mechanisms involving CD9.
• IL-16 receptor activity triggers intracellular signaling including calcium flux, tyrosine phosphorylation, and desensitization of CXCR4.
• IL-16 modulates immune cell migration, cytokine release, and neuronal excitability, linking it to inflammatory pain and lupus nephritis.
• Key research models for studying IL-16 receptor activity include CD4 knockout mice, CD9 knockout cells, and IL-16 overexpression systems.
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, and library screening services to dissect interleukin-16 receptor activity in disease models.
Description
Interleukin-16 (IL-16) is a cytokine that was originally described as a lymphocyte chemoattractant factor and has since been recognized as a key regulator of immune and neuronal functions. The biological actions of IL-16 are mediated through its receptor activity, formally annotated as GO:0042012 (interleukin-16 receptor activity), a molecular function that entails binding IL-16 and transmitting a signal across the membrane to initiate changes in cell activity. This term is essential for understanding how IL-16 exerts its pleiotropic effects, including T cell activation, macrophage modulation, and neuronal excitability. Researchers studying inflammatory diseases, neuroimmune interactions, and cancer increasingly focus on IL-16 signaling because it bridges innate and adaptive immunity. The receptor activity is unusual in that IL-16 can signal through CD4, the primary receptor, but also through CD4-independent pathways involving molecules such as CD9. This complexity makes GO:0042012 a critical node for experimental interrogation. Understanding the molecular mechanisms, regulatory networks, and disease associations of interleukin-16 receptor activity is vital for developing targeted therapies. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of GO:0042012, its associated genes, and state-of-the-art research methods including CRISPR-based models.
interleukin-16 receptor activity At A Glance
| GO ID | GO:0042012 |
|---|---|
| GO term | interleukin-16 receptor activity |
| Ontology | molecular_function |
| Synonym | IL-16R, IL-16 receptor activity |
| Definition | Combining with interleukin-16 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| Major function | Binding IL-16 and initiating intracellular signaling cascades that modulate immune cell activation, migration, and neuronal excitability. |
| Primary receptor | CD4 (cluster of differentiation 4) |
| Alternative receptor | CD9 (tetraspanin) in CD4-independent pathways |
| Associated cytokine | Interleukin-16 (IL-16) |
What Is GO:0042012?
According to the Gene Ontology, GO:0042012 (interleukin-16 receptor activity) is a molecular function defined as combining with interleukin-16 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. In simpler terms, it is the activity of a receptor protein that binds IL-16 and converts that binding event into an intracellular signal, thereby altering cellular behavior. This function is synonymous with IL-16R or IL-16 receptor activity. The receptor activity is not limited to a single protein; it can be mediated by the CD4 receptor and potentially other molecules that facilitate IL-16 signaling.
Why Is interleukin-16 receptor activity Important in Cell Biology?
Interleukin-16 receptor activity (GO:0042012) is critically important because it governs the cellular response to IL-16, a cytokine implicated in a wide range of physiological and pathological processes. IL-16 signaling through its receptor modulates T cell recruitment and activation, macrophage cytokine release, and dendritic cell function, making it a central player in inflammatory and immune responses. Beyond immunity, IL-16 receptor activity influences neuronal excitability and synaptic activity, linking it to neuroinflammatory pain and potentially neurodegenerative conditions. Dysregulated IL-16 signaling has been associated with autoimmune diseases such as lupus nephritis, where it promotes Th1 and CD8+ T cell migration. Furthermore, the ability of IL-16 to desensitize CXCR4, a chemokine receptor involved in cancer metastasis and HIV entry, highlights its broader impact on cell migration and disease progression. Therefore, understanding the molecular mechanisms and regulation of interleukin-16 receptor activity is essential for developing therapeutic strategies targeting inflammatory diseases, neuroimmune disorders, and cancer.
• IL-16 receptor activity mediates T lymphocyte chemoattraction and activation, central to adaptive immunity.
• It regulates macrophage and dendritic cell cytokine release, shaping innate immune responses.
• IL-16 signaling via its receptor modulates neuronal excitability and synaptic activity, implicating it in neuroinflammatory pain.
• The receptor activity is linked to autoimmune diseases such as lupus nephritis through promotion of Th1 and CD8+ T cell migration.
• IL-16/CD4 receptor activity can desensitize CXCR4, affecting cell migration and potentially HIV pathogenesis.
• CD4-independent IL-16 signaling via CD9 demonstrates alternative receptor mechanisms that expand its functional repertoire.
• IL-16 receptor activity is a potential therapeutic target for inflammatory and neuroimmune disorders.
• Studying GO:0042012 helps elucidate cross-talk between cytokine receptors and chemokine receptors.
• CRISPR-based models enable precise dissection of receptor components and signaling pathways.
• Understanding IL-16 receptor activity may inform development of biologics or small molecules targeting IL-16 signaling.
Core Mechanisms of interleukin-16 receptor activity
IL-16 Binding and Receptor Engagement
In simple terms: IL-16 binds to its receptor on the cell surface, like a key fitting into a lock.
The first step in interleukin-16 receptor activity is the specific binding of IL-16 to its receptor. The primary receptor for IL-16 is CD4, a glycoprotein expressed on T helper cells, monocytes, macrophages, and dendritic cells. IL-16 binding to CD4 initiates receptor clustering and activation. However, IL-16 can also signal through CD4-independent pathways, involving molecules such as CD9, a tetraspanin that facilitates alternative receptor engagement. This binding event is essential for transmitting the signal across the membrane.
Intracellular Signaling Cascades
In simple terms: Once IL-16 binds, the receptor triggers a chain of signals inside the cell.
Upon IL-16 binding, the receptor activity leads to activation of intracellular signaling cascades. These include calcium mobilization, tyrosine phosphorylation of cellular proteins, and activation of kinases such as p56lck, although some responses are independent of p56lck enzymatic activity. IL-16 signaling also results in the desensitization of CXCR4, a chemokine receptor, through a mechanism that may involve receptor cross-talk. These signaling events ultimately lead to changes in gene expression, cytoskeletal rearrangement, and cell migration.
Cellular Responses: Migration and Activation
In simple terms: The signals cause immune cells to move and become active.
IL-16 receptor activity induces directed migration (chemotaxis) of CD4+ T lymphocytes, monocytes, and eosinophils. It also promotes the release of pro-inflammatory cytokines from macrophages and dendritic cells, thereby amplifying immune responses. In T cells, IL-16 acts as a co-stimulatory factor, enhancing IL-2 receptor expression and T cell proliferation. These cellular responses are critical for host defense but can also contribute to inflammatory pathology.
Neuronal Effects and CD4-Independent Signaling
In simple terms: IL-16 can also affect nerve cells without using CD4.
Beyond the immune system, IL-16 receptor activity modulates neuronal function. IL-16 inhibits sodium channel function and reduces GluA1 phosphorylation via CD4- and CD9-independent mechanisms, leading to decreased hippocampal neuronal excitability and synaptic activity. This suggests the existence of additional, yet unidentified, receptor components for IL-16 in neurons. These findings expand the scope of GO:0042012 beyond classical immune cells.
Key Genes Involved in GO:0042012 interleukin-16 receptor activity
The following genes and proteins are directly involved in or modulate interleukin-16 receptor activity (GO:0042012) and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL16 | Encodes the cytokine interleukin-16, the ligand for the receptor. | Central to studying receptor activation; knockout and overexpression models reveal signaling outcomes. |
| CD4 | Primary receptor for IL-16; mediates binding and signal transduction. | Key target for knockout and point mutation studies to dissect IL-16 signaling. |
| CD9 | Tetraspanin that facilitates CD4-independent IL-16 signaling. | Alternative receptor component; knockout models show residual IL-16 responses. |
| LCK | Tyrosine kinase p56lck; involved in CD4-mediated signaling. | Its role in IL-16 signaling is debated; desensitization of CXCR4 is independent of its activity. |
| CXCR4 | Chemokine receptor desensitized by IL-16/CD4 signaling. | Cross-talk studies reveal modulation of chemotaxis and HIV entry. |
| GNAI1 | G protein alpha subunit involved in chemokine signaling. | Potential downstream mediator of IL-16-induced migration; not directly verified for IL-16. |
| PRKC | Protein kinase C family; may be activated downstream of IL-16 receptor. | Involved in phosphorylation cascades; experimental evidence limited. |
| MAPK1 | Mitogen-activated protein kinase 1; downstream of many cytokine receptors. | Potential mediator of IL-16-induced cytokine release; requires validation. |
| MAPK3 | Mitogen-activated protein kinase 3; similar to MAPK1. | May contribute to IL-16 signaling in macrophages; not fully characterized. |
| NFKB1 | Transcription factor regulating inflammatory genes. | Likely activated by IL-16 receptor signaling; supports cytokine release. |
| RELA | NF-kB subunit; partner of NFKB1. | Involved in IL-16-induced gene expression; experimental evidence needed. |
| IL2RA | IL-2 receptor alpha chain; upregulated by IL-16 in T cells. | Marker of T cell activation; used to assess IL-16 co-stimulation. |
| IFNG | Interferon gamma; cytokine released by T cells upon IL-16 stimulation. | Readout of Th1 response; relevant to lupus nephritis. |
| TNF | Tumor necrosis factor; pro-inflammatory cytokine modulated by IL-16. | Macrophage activation marker; IL-16 modulates its release. |
| IL6 | Interleukin-6; inflammatory cytokine. | Potential downstream effector of IL-16 signaling in macrophages. |
| CCL5 | Chemokine (RANTES) involved in T cell migration. | May be co-regulated with IL-16 in inflammatory settings. |
| CD8A | CD8 alpha chain; marker of cytotoxic T cells. | IL-16 promotes CD8+ T cell migration in lupus nephritis. |
| SCN9A | Sodium channel Nav1.7; modulated by IL-16 in neurons. | IL-16 inhibits sodium channel function in hippocampal neurons. |
How Is interleukin-16 receptor activity Regulated?
Interleukin-16 receptor activity is regulated at multiple levels. Receptor availability is controlled by CD4 expression levels, which can be modulated by cytokines and activation states. IL-16 binding can lead to homologous desensitization of the receptor, although the exact mechanisms are not fully defined. Cross-talk with other receptors, such as CXCR4, results in heterologous desensitization, where IL-16/CD4 signaling inhibits CXCR4 function independently of p56lck activity. Additionally, IL-16 itself can modulate surface receptor expression on macrophages and dendritic cells, altering their responsiveness to subsequent stimuli. These regulatory mechanisms ensure tight control of IL-16 signaling and prevent excessive inflammation.
interleukin-16 receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL16 | Lupus nephritis; inflammatory pain | IL-16 knockout mice; overexpression in spinal cord |
| CD4 | HIV infection; autoimmune inflammation | CD4 knockout T cells; point mutations in IL-16 binding domain |
| CD9 | Neuroinflammatory pain; CD4-independent signaling | CD9 knockout hippocampal neurons; IL-16 treatment |
| CXCR4 | Cancer metastasis; HIV entry | CXCR4 desensitization assays in CD4+ cells |
| SCN9A | Neuropathic pain | Sodium channel modulation in neurons treated with IL-16 |
Interleukin-16 receptor activity in inflammatory and autoimmune diseases
Dysregulated IL-16 signaling is implicated in several inflammatory and autoimmune conditions. In lupus nephritis, IL-16 promotes the migration of Th1 and CD8+ T cells into the kidney, contributing to tissue damage. Elevated IL-16 levels have been observed in various inflammatory diseases, and its receptor activity on immune cells amplifies cytokine release and chemotaxis. Targeting IL-16 receptor activity could therefore reduce pathological immune cell infiltration.
Role in neuroinflammatory pain
Recent evidence links IL-16 receptor activity to neuroinflammatory pain. Spinal IL-16 mediates inflammatory pain by promoting glial activation, and IL-16 can directly reduce neuronal excitability by inhibiting sodium channels and GluA1 phosphorylation via CD4- and CD9-independent mechanisms. These findings suggest that IL-16 receptor activity in the central nervous system contributes to pain hypersensitivity, making it a potential target for analgesic development.
Implications for cancer and HIV
IL-16 receptor activity can desensitize CXCR4, a chemokine receptor involved in cancer metastasis and HIV entry. By modulating CXCR4 function, IL-16 may influence tumor cell migration and susceptibility to HIV infection. Additionally, IL-16's effects on T cell activation and cytokine release could shape the tumor microenvironment, although direct evidence for IL-16 receptor activity in cancer remains limited.
From interleukin-16 receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CD4 mediate all IL-16 receptor activity? | CD4 knockout cell lines and primary T cells |
| What is the role of CD9 in CD4-independent IL-16 signaling? | CD9 knockout neurons and CD4/CD9 double knockout |
| How does IL-16 receptor activity affect neuronal excitability? | Knock-in of tagged IL-16 receptor components in neurons; electrophysiology |
| Can point mutations in CD4 abolish IL-16 binding? | CRISPR point mutation knock-in of CD4 variants |
| What genes are downstream of IL-16 receptor activation? | Overexpression of IL-16 in immune cells followed by RNA-seq |
| Does IL-16 receptor activity contribute to lupus nephritis? | IL-16 knockout mice in lupus models; T cell migration assays |
How to Study the interleukin-16 receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Genes essential for IL-16 receptor signaling | Identify novel receptor components |
| RNA-seq | Transcriptional changes upon IL-16 stimulation | Discover downstream pathways |
| Phosphoproteomics | Tyrosine phosphorylation events | Map signaling intermediates |
| Flow cytometry | Surface CD4 expression and cytokine release | Assess receptor levels and activation |
| Live-cell calcium imaging | Intracellular calcium flux | Measure immediate signaling |
| Patch-clamp electrophysiology | Neuronal excitability and sodium currents | Study neuronal IL-16 effects |
| Chemotaxis assay | Cell migration towards IL-16 | Evaluate receptor function |
| CXCR4 desensitization assay | CXCR4 internalization or signaling | Study receptor cross-talk |
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes required for IL-16 receptor activity. By treating cells with IL-16 and selecting for survival or reporter activation, researchers can uncover novel components of the signaling pathway. This approach is particularly useful for finding CD4-independent receptor molecules.
Transcriptomics and proteomics
RNA sequencing (RNA-seq) of cells stimulated with IL-16 can reveal gene expression changes downstream of receptor activity. Proteomic approaches, such as phosphoproteomics, can identify signaling intermediates and post-translational modifications triggered by IL-16 binding.
Imaging and flow cytometry
Flow cytometry is used to measure IL-16 receptor surface expression (e.g., CD4) and cytokine release in response to IL-16. Live-cell imaging can track receptor internalization, calcium flux, and cell migration in real time.
Electrophysiology for neuronal effects
Patch-clamp electrophysiology in hippocampal neurons treated with IL-16 can measure changes in sodium channel function and synaptic activity, providing direct evidence for IL-16 receptor activity in neurons.
How CRISPR Can Be Used to Study GO:0042012 interleukin-16 receptor activity
Knockout
CRISPR knockout of CD4, CD9, or IL16 can abolish or reduce interleukin-16 receptor activity, allowing researchers to dissect the contribution of each component. For example, CD4 knockout T cells fail to respond to IL-16, while CD9 knockout neurons show altered IL-16 effects.
Point Mutation
Point mutations in the IL-16 binding domain of CD4 or in CD9 can be introduced using CRISPR base editing or homology-directed repair to fine-map residues critical for receptor activity. Such models help distinguish binding from signaling functions.
Knock-in
Knock-in of tagged IL-16 receptor components (e.g., HA-tagged CD4) enables visualization and pull-down of receptor complexes. Knock-in of reporter genes under IL-16-responsive promoters can create sensitive readouts of receptor activity.
Overexpression
Overexpression of IL-16 or its receptor components via CRISPR activation (CRISPRa) or lentiviral delivery can amplify signaling for biochemical studies. This is useful for detecting weak interactions and downstream effects.
How EDITGENE Supports interleukin-16 receptor activity Research
Researchers studying interleukin-16 receptor activity-related genes often need to determine whether a candidate gene is causally involved in IL-16 signaling or is merely a bystander. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes associated with GO:0042012.
Contact EDITGENE today to design your custom CRISPR model for interleukin-16 receptor activity research.
Frequently Asked Questions About interleukin-16 receptor activity
What is interleukin-16 receptor activity?
Interleukin-16 receptor activity (GO:0042012) is a molecular function where a receptor binds interleukin-16 and transmits a signal across the membrane to initiate changes in cell activity, such as migration or cytokine release.
What genes are involved in interleukin-16 receptor activity?
Key genes include IL16 (the ligand), CD4 (primary receptor), and CD9 (alternative receptor component). Other signaling molecules like LCK and CXCR4 modulate the pathway.
How does IL-16 signal through its receptor?
IL-16 binds CD4 or CD9, triggering calcium flux, tyrosine phosphorylation, and kinase activation, which lead to cellular responses like chemotaxis and cytokine production.
What diseases are associated with interleukin-16 receptor activity?
It is implicated in inflammatory and autoimmune diseases such as lupus nephritis, neuroinflammatory pain, and potentially cancer and HIV through CXCR4 modulation.
Can IL-16 signal without CD4?
Yes, IL-16 can signal through CD4-independent mechanisms involving CD9, as shown in hippocampal neurons where IL-16 inhibits sodium channels without CD4 or CD9.
How is interleukin-16 receptor activity studied?
Researchers use CRISPR knockout models, RNA-seq, phosphoproteomics, flow cytometry, and electrophysiology to study IL-16 receptor signaling.
What is the role of CD4 in IL-16 receptor activity?
CD4 is the primary receptor for IL-16, mediating binding and initiating intracellular signals that lead to T cell activation and migration.
Does IL-16 receptor activity affect neurons?
Yes, IL-16 reduces neuronal excitability by inhibiting sodium channels and decreasing GluA1 phosphorylation via CD4- and CD9-independent mechanisms.
How does IL-16 receptor activity regulate CXCR4?
IL-16/CD4 signaling desensitizes CXCR4, a chemokine receptor, independently of p56lck activity, affecting cell migration and HIV entry.
What CRISPR models are available for studying IL-16 receptor activity?
EDITGENE offers knockout, point mutation, knock-in, overexpression, and library screening services for genes like CD4, CD9, and IL16 to dissect receptor function.
Conclusion
Interleukin-16 receptor activity (GO:0042012) is a multifaceted molecular function that mediates the diverse biological effects of IL-16. From immune cell chemotaxis and activation to neuronal modulation, this receptor activity plays critical roles in health and disease. The involvement of both CD4-dependent and CD4-independent pathways, along with cross-talk with CXCR4, underscores its complexity and therapeutic potential. Advances in CRISPR-based models and high-throughput methods are enabling precise dissection of the genes and mechanisms underlying IL-16 signaling. EDITGENE's comprehensive services empower researchers to generate custom cell models and accelerate discoveries in this field.
References
- 1. Center DM et al.. 1997. Interleukin-16.. Int J Biochem Cell Biol 29(11):1231-4 PMID: 9451819
- 2. Cruikshank WW et al.. 2000. Interleukin-16.. J Leukoc Biol 67(6):757-66 PMID: 10857846
- 3. Zhu X et al.. 2024. Spinal interleukin-16 mediates inflammatory pain via promoting glial activation.. Int Immunopharmacol 127:111411 PMID: 38113689
- 4. Wangriatisak K et al.. 2025. Interleukin 16 in lupus nephritis-a role for Th1 and CD8+ T cell migration.. Clin Exp Immunol 219(1) PMID: 41061119
- 5. Cruikshank WW et al.. 1998. Signaling and functional properties of interleukin-16.. Int Rev Immunol 16(5-6):523-40 PMID: 9646175
- 6. Hermann E et al.. 1999. Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells.. Immunology 97(2):241-8 PMID: 10447738
- 7. Hridi SU et al.. 2019. Interleukin-16 inhibits sodium channel function and GluA1 phosphorylation via CD4- and CD9-independent mechanisms to reduce hippocampal neuronal excitability and synaptic activity.. Mol Cell Neurosci 95:71-78 PMID: 30738184
- 8. Van Drenth C et al.. 2000. Desensitization of CXC chemokine receptor 4, mediated by IL-16/CD4, is independent of p56lck enzymatic activity.. J Immunol 165(11):6356-63 PMID: 11086073
